BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23211552)

  • 1. Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.
    Kramer JH; Arnoldi E; François CJ; Wentland AL; Nikolaou K; Wintersperger BJ; Grist TM
    Invest Radiol; 2013 Mar; 48(3):121-8. PubMed ID: 23211552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study).
    Li Y; Li X; Li D; Lu J; Xing X; Yan F; Li Y; Wang X; Iezzi R; De Cobelli F
    AJNR Am J Neuroradiol; 2013 Apr; 34(4):847-54. PubMed ID: 23042922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T.
    Attenberger UI; Michaely HJ; Wintersperger BJ; Sourbron SP; Lodemann KP; Reiser MF; Schoenberg SO
    Eur Radiol; 2008 Jun; 18(6):1260-8. PubMed ID: 18278504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI.
    Khouri Chalouhi K; Papini GDE; Bandirali M; Sconfienza LM; Di Leo G; Sardanelli F
    Eur J Radiol; 2014 Jul; 83(7):1245-1249. PubMed ID: 24816087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
    Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
    Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine.
    Woodard PK; Chenevert TL; Sostman HD; Jablonski KA; Stein PD; Goodman LR; Londy FJ; Narra V; Hales CA; Hull RD; Tapson VF; Weg JG
    Int J Cardiovasc Imaging; 2012 Feb; 28(2):295-301. PubMed ID: 21337023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
    Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
    Lee CH; Vellayappan B; Taupitz M; Hamm B; Asbach P
    Eur Radiol; 2019 Dec; 29(12):6982-6990. PubMed ID: 31264013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement characteristics and impact on image quality of two gadolinium chelates at equimolar doses for time-resolved 3-Tesla MR-angiography of the calf station.
    Hansmann J; Michaely HJ; Morelli JN; Luckscheiter A; Schoenberg SO; Attenberger UI
    PLoS One; 2014; 9(6):e99079. PubMed ID: 24893292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.
    Clauser P; Helbich TH; Kapetas P; Pinker K; Bernathova M; Woitek R; Kaneider A; Baltzer PAT
    J Magn Reson Imaging; 2019 Apr; 49(4):1157-1165. PubMed ID: 30552829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques.
    Wuesten O; Morelli JN; Miller MW; Tuzun E; Lenox MW; Fossum TW; Trelles M; Cotes C; Krombach GA; Runge VM
    J Magn Reson Imaging; 2012 Nov; 36(5):1203-12. PubMed ID: 22826184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography.
    Herborn CU; Lauenstein TC; Ruehm SG; Bosk S; Debatin JF; Goyen M
    Invest Radiol; 2003 Jan; 38(1):27-33. PubMed ID: 12496518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).
    Seidl Z; Vymazal J; Mechl M; Goyal M; Herman M; Colosimo C; Pasowicz M; Yeung R; Paraniak-Gieszczyk B; Yemen B; Anzalone N; Citterio A; Schneider G; Bastianello S; Ruscalleda J
    AJNR Am J Neuroradiol; 2012 Jun; 33(6):1050-8. PubMed ID: 22383237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
    McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
    Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
    Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
    J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 0.5 M gadoterate and 1.0 M gadobutrol in peripheral MRA: a prospective, single-center, randomized, crossover, double-blind study.
    Haneder S; Attenberger UI; Schoenberg SO; Loewe C; Arnaiz J; Michaely HJ
    J Magn Reson Imaging; 2012 Nov; 36(5):1213-21. PubMed ID: 22848033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography.
    Morelli JN; Runge VM; Ai F; Zhang W; Li X; Schmitt P; McNeal G; Miller M; Lennox M; Wusten O; Schoenberg SO; Attenberger UI
    Invest Radiol; 2012 Jun; 47(6):376-82. PubMed ID: 22543971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
    Loewe C; Arnaiz J; Krause D; Marti-Bonmati L; Haneder S; Kramer U;
    AJR Am J Roentgenol; 2015 Jun; 204(6):1311-21. PubMed ID: 26001243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.